Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

被引:74
作者
Samuel, Didier [1 ]
Coilly, Audrey [1 ]
机构
[1] Univ Paris South, Ctr Hepatobiliaire, Paul Brousse Hosp, INSERM,Paris South Res Unit 1193, 12 Ave Paul Vaillant Couturier, F-94800 Paris, France
关键词
Liver transplantation; Meld score; Hepatocellular carcinoma; Viral hepatitis; Acute on chronic liver failure; Cirrhosis; Liver transplant waiting list; Alcoholic cirrhosis; INTENSIVE-CARE-UNIT; CIRRHOTIC-PATIENTS; HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; ALPHA-FETOPROTEIN; MODEL; MORTALITY; MULTICENTER; CANDIDATES; ALLOCATION;
D O I
10.1186/s12916-018-1110-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The results of liver transplantation are excellent, with survival rates of over 90 and 80% at 1 and 5 years, respectively. The success of liver transplantation has led to an increase in the indications for liver transplantation. Generally, priorities are given to cirrhotic patients with a high Model for End-Stage Liver Disease (MELD) score on the principle of the sickest first and to patients with hepatocellular carcinoma (HCC) on the principle of priority points according to the size and number of nodules of HCC. These criteria can lead to a 'competition' on the waiting list between the above patients and those who are cirrhotic and have an intermediate MELD score or with life-threatening liver diseases not well described by the MELD score. For this latter group of patients, 'MELD exception' points can be arbitrarily given. Discussion: The management of patients on the waiting list is of prime importance to avoid death and drop out from the waiting list as well as to improve post-transplant survival rates. For the more severe cases who may swiftly access liver transplantation, it is essential to rapidly determine whether liver transplantation is indeed indicated, and to organise a fast workup ahead of this. It is also essential to identify the ideal timing for liver transplantation in order to minimise mortality rates. For patients with HCC, a bridge therapy is frequently required to avoid progression of HCC and to maintain patients within the criteria of liver transplantation as well as to reduce the risk of post-transplant recurrence of HCC. For patients with cirrhosis and intermediate MELD score, waiting time can exceed 1 year; therefore, regular follow-up and management are essential to maintain the patient alive on the waiting list and to achieve a good survival after liver transplantation. Conclusion: There is a diversity of patients on the waiting list for transplantation and equity should be preserved between those with cirrhosis of high and intermediate severity and those with HCC. The management of patients on the waiting list is an essential component of the success of liver transplantation.
引用
收藏
页数:5
相关论文
共 29 条
[1]   Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3 [J].
Artru, Florent ;
Louvet, Alexandre ;
Ruiz, Isaac ;
Levesque, Eric ;
Labreuche, Julien ;
Ursic-Bedoya, Jose ;
Lassailly, Guillaume ;
Dharancy, Sebastien ;
Boleslawski, Emmanuel ;
Lebuffe, Gilles ;
Kipnis, Eric ;
Ichai, Philippe ;
Coilly, Audrey ;
De Martin, Eleonora ;
Antonini, Teresa Maria ;
Vibert, Eric ;
Jaber, Samir ;
Herrerro, Astrid ;
Samuel, Didier ;
Duhamel, Alain ;
Pageaux, Georges-Philippe ;
Mathurin, Philippe ;
Saliba, Faouzi .
JOURNAL OF HEPATOLOGY, 2017, 67 (04) :708-715
[2]   Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study [J].
Belli, Luca Saverio ;
Berenguer, Marina ;
Cortesi, Paolo Angelo ;
Strazzabosco, Mario ;
Rockenschaub, Susanne-Rasoul ;
Martini, Silvia ;
Morelli, Cristina ;
Donato, Francesca ;
Volpes, Riccardo ;
Pageaux, Georges-Philippe ;
Coilly, Audrey ;
Fagiuoli, Stefano ;
Amaddeo, Giuliana ;
Perricone, Giovanni ;
Vinaixa, Carmen ;
Berlakovich, Gabriela ;
Facchetti, Rita ;
Polak, Wojciech ;
Muiesan, Paolo ;
Duvoux, Christophe .
JOURNAL OF HEPATOLOGY, 2016, 65 (03) :524-531
[3]   The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition [J].
Crespo, Gonzalo ;
Trota, Nuria ;
Londono, Maria-Carlota ;
Mauro, Ezequiel ;
Baliellas, Carme ;
Castells, Lluis ;
Castellote, Jose ;
Tort, Jaume ;
Forns, Xavier ;
Navasa, Miquel .
JOURNAL OF HEPATOLOGY, 2018, 69 (01) :11-17
[4]   Personalized Adapted Physical Activity Before Liver Transplantation: Acceptability and Results [J].
Debette-Gratien, Marilyne ;
Tabouret, Tessa ;
Antonini, Marie-Therese ;
Dalmay, Francois ;
Carrier, Paul ;
Legros, Romain ;
Jacques, Jeremie ;
Vincent, Francois ;
Sautereau, Denis ;
Samuel, Didier ;
Loustaud-Ratti, Veronique .
TRANSPLANTATION, 2015, 99 (01) :145-150
[5]   Challenges to Liver Transplantation and Strategies to Improve Outcomes [J].
Dutkowski, Philipp ;
Linecker, Michael ;
DeOliveira, Michelle L. ;
Muellhaupt, Beat ;
Clavien, Pierre-Alain .
GASTROENTEROLOGY, 2015, 148 (02) :307-323
[6]   Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria [J].
Duvoux, Christophe ;
Roudot-Thoraval, Francoise ;
Decaens, Thomas ;
Pessione, Fabienne ;
Badran, Hanaa ;
Piardi, Tullio ;
Francoz, Claire ;
Compagnon, Philippe ;
Vanlemmens, Claire ;
Dumortier, Jerome ;
Dharancy, Sebastien ;
Gugenheim, Jean ;
Bernard, Pierre-Henri ;
Adam, Rene ;
Radenne, Sylvie ;
Muscari, Fabrice ;
Conti, Filomena ;
Hardwigsen, Jean ;
Pageaux, Georges-Philippe ;
Chazouilleres, Olivier ;
Salame, Ephrem ;
Hilleret, Marie-Noelle ;
Lebray, Pascal ;
Abergel, Armand ;
Debette-Gratien, Marilyne ;
Kluger, Michael D. ;
Mallat, Ariane ;
Azoulay, Daniel ;
Cherqui, Daniel .
GASTROENTEROLOGY, 2012, 143 (04) :986-+
[7]   EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure [J].
不详 .
JOURNAL OF HEPATOLOGY, 2017, 66 (05) :1047-1081
[8]   EASL Clinical Practice Guidelines: Liver transplantation [J].
Burra, Patrizia ;
Burroughs, Andrew ;
Graziadei, Ivo ;
Pirenne, Jacques ;
Valdecasas, Juan Carlos ;
Muiesan, Paolo ;
Samuel, Didier ;
Forns, Xavier ;
Burroughs, Andrew .
JOURNAL OF HEPATOLOGY, 2016, 64 (02) :433-485
[9]   New perspectives for preventing hepatitis C virus liver graft infection [J].
Felmlee, Daniel J. ;
Coilly, Audrey ;
Chung, Raymond T. ;
Samuel, Didier ;
Baumert, Thomas F. .
LANCET INFECTIOUS DISEASES, 2016, 16 (06) :735-745
[10]   Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis [J].
Gustot, Thierry ;
Fernandez, Javier ;
Garcia, Elisabet ;
Morando, Filippo ;
Caraceni, Paolo ;
Alessandria, Carlo ;
Laleman, Wim ;
Trebicka, Jonel ;
Elkrief, Laure ;
Hopf, Corinna ;
Solis-Munoz, Pablo ;
Saliba, Faouzi ;
Zeuzem, Stefan ;
Albillos, Augustin ;
Benten, Daniel ;
Montero-Alvarez, Jose Luis ;
Chivas, Maria Teresa ;
Concepcion, Mar ;
Cordoba, Juan ;
McCormick, Aiden ;
Stauber, Rudolf ;
Vogel, Wolfgang ;
de Gottardi, Andrea ;
Welzel, Tania M. ;
Domenicali, Marco ;
Risso, Alessandro ;
Wendon, Julia ;
Deulofeu, Carme ;
Angeli, Paolo ;
Durand, Francois ;
Pavesi, Marco ;
Gerbes, Alexander ;
Jalan, Rajiv ;
Moreau, Richard ;
Gines, Pere ;
Bernardi, Mauro ;
Arroyo, Vicente .
HEPATOLOGY, 2015, 62 (01) :243-252